APA (7th ed.) Citation

Sun, H., Wang, X., Li, Y., Shen, Y., Zhang, L., Xu, Y., . . . Fan, X. (2024). Targeting Liver Xor by GalNAc-siRNA Is an Effective Strategy for Hyperuricemia Therapy. Pharmaceutics, 16(7), 938. https://doi.org/10.3390/pharmaceutics16070938

Chicago Style (17th ed.) Citation

Sun, Huiyan, Xinxia Wang, Yongqiang Li, Yingzhi Shen, Lin Zhang, Yingjie Xu, Junling Liu, and Xuemei Fan. "Targeting Liver Xor by GalNAc-siRNA Is an Effective Strategy for Hyperuricemia Therapy." Pharmaceutics 16, no. 7 (2024): 938. https://doi.org/10.3390/pharmaceutics16070938.

MLA (9th ed.) Citation

Sun, Huiyan, et al. "Targeting Liver Xor by GalNAc-siRNA Is an Effective Strategy for Hyperuricemia Therapy." Pharmaceutics, vol. 16, no. 7, 2024, p. 938, https://doi.org/10.3390/pharmaceutics16070938.